{rfName}
Ph

Indexed in

License and use

Citations

7

Altmetrics

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

Lozano, AliciaAuthorPlanas, IsabelAuthorCirauqui, BeatrizAuthorMesia, RicardAuthor

Share

July 13, 2020
Publications
>
Meeting Abstract
No

Phase II trial of high-dose melatonin oral gel for the prevention and treatment of oral mucositis in H&N cancer patients undergoing chemoradiation (MUCOMEL).

Publicated to:Journal Of Clinical Oncology. 36 (15): 6007-6007 - 2018-05-20 36(15), DOI: 10.1200/JCO.2018.36.15_suppl.6007

Authors: Lozano, A; Marruecos, J; Rubió-Casadevall, J; Farre, N; Lopez-Pousa, A; Giralt, J; Planas, I; Cirauqui, B; Lanzuela, M; Morera, R; Escribano, A; Gomez-Millan, J; Toledo, MD; Masedo, GV; Cascallar, L; Grima, P; Valenti, V; Tarrago, C; Bosser, R; Mesia, R

Affiliations

Hosp Clin San Carlos, Madrid, Spain - Author
Hosp Germans Trias Pujol, Med Oncol Dept, Catalan Inst Oncol, Badalona, Spain - Author
Hosp Josep Trueta, Girona, Spain - Author
Hosp Sant Pau, Barcelona, Spain - Author
Hosp Santa Creu & Sant Pau, Barcelona, Spain - Author
Hosp Santa Tecla, Tarragona, Spain - Author
Hosp Univ La Paz, Madrid, Spain - Author
Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain - Author
Hosp Univ Virgen Victoria, Malaga SPA, Malaga, Spain - Author
Hosp Univ Virgen Victoria, Malaga, Spain - Author
IDIBELL, Catalan Inst Oncol, Barcelona, Spain - Author
Inst Catala Oncol Badalona H U Germans Trias Pu, Badalona, Spain - Author
Inst Catala Oncol Girona SPA, Girona, Spain - Author
Inst Catala Oncol, Barcelona, Spain - Author
Miguel Servet Univ Hosp, Aragon Hlth Sci Inst, Dept Radiat Oncol, Zaragoza, Spain - Author
Spherium Biomed SL, Barcelona, Spain - Author
Vall Hebron Univ Hosp, Barcelona, Spain - Author
See more

Abstract

Keywords

Good health and well-being

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Journal Of Clinical Oncology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2018, it was in position 5/229, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 2.22, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-03, the following number of citations:

  • WoS: 7
  • Open Alex: 8

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-03:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 15.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 15 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 1.
  • The number of mentions on the social network X (formerly Twitter): 1 (Altmetric).
Continuing with the social impact of the work, it is important to emphasize that, due to its content, it can be assigned to the area of interest of ODS 3 - Good Health and Well-Being, with a probability of 82% according to the mBERT algorithm developed by Aurora University.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Lozano Borbalas, Alicia) and Last Author (Mesia Nin, Ricard).